Complete response to imatinib mesylate treatment in a 12-month-old patient with chronic myeloid leukemia. [electronic resource]
Producer: 20080515Description: 1078 p. digitalISSN:- 1545-5017
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Fusion Proteins, bcr-abl -- genetics
- Humans
- Imatinib Mesylate
- Infant
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Piperazines -- therapeutic use
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- therapeutic use
- RNA, Messenger -- genetics
- Remission Induction
- Reverse Transcriptase Polymerase Chain Reaction
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.